ADVFN - Advanced Financial Network.
HOME» NASDAQ » C » CYTK Stock Price » CYTK Stock News

Cytokinetics Incorporated Share News

 Cytokinetics, Incorporated (mm) Stock Price
CYTK Stock Price
 Cytokinetics, Incorporated (mm) Stock Chart
CYTK Stock Chart
 Cytokinetics, Incorporated (mm) Stock News
CYTK Stock News
 Cytokinetics, Incorporated (mm) Company Information
CYTK Company Information
 Cytokinetics, Incorporated (mm) Stock Trades
CYTK Stock Trades

Registration Effectiveness Orders Issued By The SEC

The following table includes registration statements and post-effective amendments that were declared effective by the Securities and Exchange Commission on the most recently completed business day. The Securities Act of 1933 requires companies offering securities to file a registration statement with the SEC that discloses material facts for investors. The SEC staff reviews registration statements and declares them "effective" if companies satisfy the disclosure rules. REGISTRATIONS EFFECTIVE AS OF December 8, 2011 IPO: Memorial Production Partners LP (MEMP) File Number: 333-175090 Date of Original Registration: 6/23/11 Form Type: S-1 Securities Registered: $287,500,000 Common units representing limited partner interests Selling Holder: No Rose Rock Midstream, L.P. (RRMS) File Number: 333-176260 Date of Original Registration: 8/12/11 Form Type: S-1 Securities Registered: $181,125,000 Common units representing limited partner interests Selling Holder: No STOCK: ADVENTO, INC. File Number: 333-174607 Date of Original Registration: 5/31/11 Form Type: S-1 Securities Registered: 2,000,000 SHARES OF COMMON STOCK Selling Holder: No Advaxis, Inc. (ADXS) File Number: 333-178172 Date of Original Registration: 11/23/11 Form Type: S-1 Securities Registered: 24,130,782 Shares of Common Stock Selling Holder: Yes Campus Crest Communities, Inc. (CCG) File Number: 333-177648 Date of Original Registration: 11/1/11 Form Type: S-3 Securities Registered: 285,593 Shares of Common Stock Selling Holder: Yes GENERAL ELECTRIC CO (GE) File Number: 333-177803 Date of Original Registration: 11/8/11 Form Type: S-3 Securities Registered: 75,000,000 shares of Common Stock, $0.06 par value per share Selling Holder: No TIGER JIUJIANG MINING, INC. File Number: 333-166823 Date of Original Registration: 5/14/10 Form Type: S-1 Securities Registered: 1,000,000 minimum - 2,000,000 maximum shares offered by Tiger Jiujiang Mining, Inc. at a price of $0.05 per share; 1,500,000 shares offered by selling shareholders at a price of $0.05 per share Selling Holder: Yes S-4s and F-4s: Whitestone REIT File Number: 333-178098 Date of Original Registration: 11/22/11 Form Type: S-4 Securities Registered: Offer To Exchange up to 1,321,431 Class B common shares; Up to 867,789 Class A common shares; Up to 453,642 Units of Limited Partnership Selling Holder: No MIXED SECURITIES: CYTOKINETICS INC (CYTK) File Number: 333-178189 Date of Original Registration: 11/25/11 Form Type: S-3 Securities Registered: $100,000,000 COMMON STOCK, PREFERRED STOCK, WARRANTS Selling Holder: No Campus Crest Communities, Inc. (CCG) File Number: 333-177646 Date of Original Registration: 11/1/11 Form Type: S-3 Securities Registered: $750,000,000 Common Stock, Preferred Stock, Debt Securities, Depositary Shares, Warrants Selling Holder: No GENERAL ELECTRIC CO (GE) File Number: 333-177804 Date of Original Registration: 11/8/11 Form Type: S-3 Securities Registered: $20,000,000,000 Senior Debt Securities, Subordinated Debt Securities, Preferred Stock, par value $1.00 per share, Common Stock, par value $0.06 per share, Warrants, Delayed Delivery Contracts, Guarantees Selling Holder: No

Stock News for Cytokinetics Incorporated (CYTK)
DateTimeHeadline
02/03/201616:00:00Cytokinetics to Participate in Upcoming Investor Conferences
02/02/201616:00:00Cytokinetics to Announce Fourth Quarter Results on February...
01/26/201608:23:38Amended Statement of Ownership (sc 13g/a)
01/22/201618:38:34Amended Statement of Changes in Beneficial Ownership (4/a)
01/11/201607:45:54Current Report Filing (8-k)
01/11/201607:30:00Cytokinetics Outlines Vision 2020 Strategic Initiative to Advance...
01/10/201612:00:00Cytokinetics Presents Analyses Demonstrating Predictive Value...
01/06/201614:51:21Statement of Changes in Beneficial Ownership (4)
01/06/201614:51:21Statement of Changes in Beneficial Ownership (4)
01/06/201614:50:55Statement of Changes in Beneficial Ownership (4)
01/06/201614:50:27Statement of Changes in Beneficial Ownership (4)
01/06/201614:50:27Statement of Changes in Beneficial Ownership (4)
01/04/201607:35:30Current Report Filing (8-k)
01/04/201607:30:00Cytokinetics Announces Start of Phase 2 Clinical Trial of CK-2127107...
12/08/201507:30:00Cure SMA and Cytokinetics Announce Partnership to Advance Education...
12/04/201510:02:03The 3 Most Important Drugs in Amgen's Pipeline
11/24/201516:00:00Cytokinetics to Present at 27th Annual Piper Jaffray Healthcare...
11/16/201517:29:44Current Report Filing (8-k)
11/13/201512:02:03A Bounty of Data Pushes Amgen Higher by 14% in October
11/09/201508:06:56Current Report Filing (8-k)

Cytokinetics Incorporated and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2015 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad